Skip to main content
Mercator Medical logo

Mercator Medical — Investor Relations & Filings

Ticker · MRC ISIN · PLMRCTR00015 LEI · 259400YONW18M3H4WX66 WAR Manufacturing
Open in API
Filings indexed 1,123 across all filing types
Latest filing 2024-11-20 Earnings Release
Country PL Poland
Listing WAR MRC

About Mercator Medical

https://en.mercatormedical.eu/

Mercator Medical is a manufacturer of medical gloves and a distributor of single-use medical materials. The company's core product portfolio includes a variety of disposable gloves, such as surgical, diagnostic, sterile, and protective types, alongside other disposable medical supplies. It operates on a dual model: as a manufacturer with a global distribution network selling to numerous countries worldwide, and as a distributor primarily focused on European markets. The business centers on providing single-use medical devices and personal protective equipment.

Recent filings

Filing Released Lang Actions
Szacunkowe wyniki trzeciego kwartału 2024 r. - Content (PL)
Earnings Release Classification · 100% confidence The document provides preliminary, estimated financial results (revenues, EBITDA, net loss) for the third quarter (III kw. 2024) compared to previous periods. This content structure—presenting key financial highlights for a specific reporting period (Q3 2024) before the full report is ready—is characteristic of an Earnings Release (ER). The text explicitly states that the consolidated quarterly report is being prepared and will be published later (November 29th), confirming this is the initial announcement of results, not the full report itself. The document length is short, but its primary function is announcing the results, fitting ER better than RPA or RNS. Q3 2024
2024-11-20 Polish
Zawiadomienie
Major Shareholding Notification Classification · 98% confidence The document is written in Polish and contains headers like "Zawiadomienie na podstawie art. 69 ust. 1 lub 2 w zw. z art. 87 ust. 1 pkt 5 ustawy o ofercie" (Notification pursuant to Art. 69 sec. 1 or 2 in connection with Art. 87 sec. 1 point 5 of the Public Offering Act). It details changes in shareholdings ("stan posiadania") among participants of a shareholder agreement ("porozumienia akcjonariuszy"). This structure, focusing on changes in significant share ownership thresholds and insider/group dealings under specific regulatory articles (Art. 87), strongly suggests a notification related to major shareholding changes or insider transactions. Given the context of reporting changes in ownership percentage (e.g., 64.8%, 72.71%) due to an event described as 'Zbycie poza obrotem w ramach skupu akcji własnych' (Disposal outside trading within a share buyback), the most fitting category is Major Shareholding Notification (MRQ), as it tracks changes in ownership percentages crossing thresholds, even if related to internal transactions or agreements. It is not a full financial report (10-K, IR) or a simple dividend notice (DIV).
2024-11-05 Polish
Zawiadomienie
Major Shareholding Notification Classification · 98% confidence The document text is titled "Zawiadomienie na podstawie art. 69 ust. 1 lub 2 ustawy o ofercie (wypełnia akcjonariusz)" which translates to a notification based on Article 69 of the Public Offering Act. This type of filing in Polish markets (KNF regulations) typically concerns changes in significant shareholdings or voting rights thresholds. The content details 'Stan posiadania podmiotu' (holding status) before and after a change, involving specific share counts and percentage of capital/votes. This directly corresponds to the definition of Major Shareholding Notification (MRQ), which covers changes in significant share ownership levels crossing thresholds.
2024-11-05 Polish
Znaczne pakiety akcji - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document text is very short (555 characters) and explicitly states that the management ('Zarząd spółki') is submitting notifications received on November 5, 2024, regarding changes in the total number of votes held by specific shareholders (Mr. Wiesław Żyznowski and Anabaza RAIF V.C.I.C. Limited). This content directly relates to changes in significant share ownership thresholds, as mandated by Polish public offering laws (art. 69 ustawy o ofercie publicznej). This perfectly matches the definition of a Major Shareholding Notification (MRQ). It is not a full report, but a notification of a change in ownership.
2024-11-05 Polish
Powiadomienie o transakcji
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction/transactions referred to in Article 19(1) of the MAR Regulation). It details a transaction involving an executive (Wiesław Żyznowski, Chairman of the Supervisory Board) selling shares ('Zbycie') of MERCATOR MEDICAL SPÓŁKA AKCYJNA. Article 19 of MAR (Market Abuse Regulation) mandates reporting of transactions conducted by persons discharging managerial responsibilities (PDMRs). This specific reporting requirement for insider trades by directors/executives aligns directly with the definition for Director's Dealing (DIRS).
2024-11-05 Polish
Powiadomienie o transakcji - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document text is very short (270 characters) and states that the Management Board ('Zarząd') is attaching a notification received on November 4, 2024, from Mr. Wiesław Żyznowski, prepared based on Article 19(1) of the MAR Regulation. Article 19 of MAR relates to transactions by persons discharging managerial responsibilities (PDMRs). This type of transaction report is typically classified as Director's Dealing (DIRS). However, given the extremely short length and the phrasing 'przekazuje w załączeniu do niniejszego raportu' (transmits in attachment to this report), it strongly suggests this is an announcement *about* the attached document rather than the full filing itself. Since DIRS is a specific category for insider trades, and this document is merely announcing the receipt and attachment of that specific notification, it fits best under the general regulatory announcement category, RNS, or potentially DIRS if the content of the attachment is assumed to be the core subject. Given the context of MAR Article 19, the underlying event is Director's Dealing (DIRS). If the document itself were the full transaction report, it would be DIRS. Since it is an announcement *of* the report, it leans towards RPA or RNS. However, DIRS is a specific category for the subject matter (insider trades). I will classify it as DIRS because the core subject matter is a director's dealing notification, which is a specific regulatory filing type, even if this specific document is the cover letter/announcement.
2024-11-05 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.